A detailed history of Quest Partners LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Quest Partners LLC holds 5,235 shares of ELAN stock, worth $78,158. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,235
Previous 5,619 6.83%
Holding current value
$78,158
Previous $68 Million 19.22%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$10.04 - $12.47 $3,855 - $4,788
-384 Reduced 6.83%
5,235 $55 Million
Q4 2024

Feb 07, 2025

SELL
$11.63 - $14.67 $123,068 - $155,237
-10,582 Reduced 65.32%
5,619 $68 Million
Q3 2024

Nov 07, 2024

BUY
$11.85 - $15.47 $173,069 - $225,939
14,605 Added 915.1%
16,201 $238 Million
Q2 2024

Aug 06, 2024

SELL
$12.93 - $18.45 $25,743 - $36,733
-1,991 Reduced 55.51%
1,596 $23 Million
Q1 2024

May 09, 2024

BUY
$14.37 - $16.46 $51,545 - $59,042
3,587 New
3,587 $58.4 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $7.08B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.